Lupin announces new Centre of Excellence for inhalation research in Florida, US

The new facility has brought 45 skilled jobs to South Florida

Indian generics manufacturer Lupin has opened its new Centre of Excellence for Inhalation Research in Coral Springs, Florida, US.

Lupin's new facility has brought 45 skilled jobs to the region. It will focus on the research and development of inhalation products for the treatment of asthma, allergic rhinitis, chronic obstructive pulmonary diseases and other lung diseases.

Local and state leaders, including Florida Lieutenant Governor Carlos Lopez-Cantera, Florida Department of Economic Opportunity Director Jesse Panuccio, and Mayor Skip Campbell, were on site to celebrate the opening of the new facility with a ribbon-cutting ceremony.'We are delighted to be making our mark in South Florida,' said Vinita Gupta, CEO, Lupin.

'With the talent and resources this state provides, our Coral Springs expansion will further strengthen our ability to bring quality, affordable pharmaceuticals to patients in the US and other key markets globally. The new inhalation research and development facility is a significant step forward in our journey to emerge as a global speciality pharmaceutical player.'

Lupin's Coral Springs facility was made possible through collaboration among Enterprise Florida, the Florida Department of Economic Opportunity, CareerSource Florida, Broward County and the Greater Fort Lauderdale Alliance.

Companies